Center for Scientific Review; Notice of Closed Meetings, 54585-54586 [E9-25404]

Download as PDF Federal Register / Vol. 74, No. 203 / Thursday, October 22, 2009 / Notices proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel Production, Analysis and Distribution of Cannabis and Marijuana Cigarettes and Related Materials (7773). Date: October 28, 2009. Time: 1 p.m. to 2 p.m. Agenda: To review and evaluate contract proposals. Place: National Institutes of Health, 6101 Executive Boulevard, Rockville, MD 20852 (Telephone Conference Call). Contact Person: Scott Chen, PhD, Scientific Review Officer, Office of Extramural Affairs, National Institute on Drug Abuse, National Institutes of Health, DHHS, 6101 Executive Boulevard, Room 220, MSC 8401, Bethesda, MD 20892, 301–443–9511, chensc@mail.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.279, Drug Abuse and Addiction Research Programs, National Institutes of Health, HHS) Dated: October 15, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–25375 Filed 10–21–09; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health dcolon on DSK2BSOYB1PROD with NOTICES Center for Scientific Review; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the Center for Scientific Review Special Emphasis Panel, November 4, 2009, 8 a.m. to November 4, 2009, 5 p.m., Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD, 20814 which was published in the Federal Register on October 2, 2009, 74 FR 50975–50977. The meeting will be held November 5, 2009. The meeting time and location remain the same. The meeting is closed to the public. Dated: October 15, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–25413 Filed 10–21–09; 8:45 am] BILLING CODE 4140–01–P VerDate Nov<24>2008 15:13 Oct 21, 2009 Jkt 220001 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel, Cardiovascular Regeneration. Date: November 8–10, 2009. Time: 4 p.m. to 4 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892. (Virtual Meeting.) Contact Person: Joseph Thomas Peterson, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4118, MSC 7814, Bethesda, MD 20892. 301–443– 8130. Name of Committee: Center for Scientific Review Special Emphasis Panel, Small Business: Biological Chemistry and Biophysics. Time: November 9–10, 2009. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Sergei Ruvinov, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4158, MSC 7806, Bethesda, MD 20892. 301–435– 1180. ruvinser@csr.nih.gov. Name of Committee: AIDS and Related Research Integrated Review Group, AIDS Immunology and Pathogenesis Study Section. Date: November 10, 2009. Time: 8 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: Ritz Carlton Hotel, 1150 22nd Street, NW., Washington, DC 20037. Contact Person: Shiv A. Prasad, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5220, MSC 7852, Bethesda, MD 20892. 301–443– 5779. prasads@csr.nih.gov. PO 00000 Frm 00051 Fmt 4703 Sfmt 4703 54585 Name of Committee: Center for Scientific Review Special Emphasis Panel, Social Science and Population Studies. Date: November 11–12, 2009. Time: 4 p.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Westin St. Francis Hotel, 335 Powell Street, San Francisco, CA 94102. Contact Person: Valerie Durrant, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3148, MSC 7770, Bethesda, MD 20892. (301) 435– 3554. durrantv@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, Small Business: Biomaterials, Delivery Systems, and Nanotechnology. Date: November 13, 2009. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Doubletree Hotel Bethesda, 8120 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Alexander Gubin, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4196, MSC 7812, Bethesda, MD 20892. 301–435– 2902. gubina@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, RFA–OD– 09–008 BRDG–SPAN and RFA–OD–09–009 Catalyst ARRA Review Panel 7. Date: November 17–18, 2009. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: William F. Bolger Center, 9600 Newbridge Drive, Potomac, MD 20854. Contact Person: Rossana Berti, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3191, MSC 7846, Bethesda, MD 20892. 301–402– 6411. bertiros@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, BRDG– SPAN and Catalyst ARRA Grants: Population Sciences and Epidemiology. Date: November 18, 2009. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Hilton Washington/Rockville, 1750 Rockville Pike, Rockville, MD 20852. Contact Person: Suzanne Ryan, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3139, Bethesda, MD 20892. (301) 435–1712. ryansj@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, Fellowship: Technology Development. Date: November 19, 2009. Time: 12 p.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892. (Telephone Conference Call.) Contact Person: Alessandra M. Bini, PhD, Scientific Review Officer, Center for E:\FR\FM\22OCN1.SGM 22OCN1 54586 Federal Register / Vol. 74, No. 203 / Thursday, October 22, 2009 / Notices Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5142, MSC 7840, Bethesda, MD 20892. 301–435– 1024. binia@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: October 14, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–25404 Filed 10–21–09; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Subcommittee for Dose Reconstruction Reviews (SDRR), Advisory Board on Radiation and Worker Health (ABRWH), National Institute for Occupational Safety and Health (NIOSH) dcolon on DSK2BSOYB1PROD with NOTICES In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention, announces the following meeting for the aforementioned subcommittee: Time and Date: 10 a.m.–5 p.m., November 5, 2009. Place: Cincinnati Airport Marriott, 2395 Progress Drive, Hebron, Kentucky 41018, Telephone: (859) 334–4611, Fax: (859) 334–4619. Status: Open to the public, but without a public comment period. To access by conference call dial the following information 1 (866) 659–0537, Participant Pass Code 9933701. Background: The Advisory Board was established under the Energy Employees Occupational Illness Compensation Program Act of 2000 to advise the President on a variety of policy and technical functions required to implement and effectively manage the new compensation program. Key functions of the Advisory Board include providing advice on the development of probability of causation guidelines that have been promulgated by the Department of Health and Human Services (HHS) as a final rule; advice on methods of dose reconstruction which have also been promulgated by HHS as a final rule; advice on the scientific validity and quality of dose estimation and reconstruction efforts being performed for purposes of the compensation program; and advice on VerDate Nov<24>2008 15:13 Oct 21, 2009 Jkt 220001 petitions to add classes of workers to the Special Exposure Cohort (SEC). In December 2000, the President delegated responsibility for funding, staffing, and operating the Advisory Board to HHS, which subsequently delegated this authority to CDC. NIOSH implements this responsibility for CDC. The charter was issued on August 3, 2001, renewed at appropriate intervals, and will expire on August 3, 2011. Purpose: The Advisory Board is charged with (a) providing advice to the Secretary, HHS, on the development of guidelines under Executive Order 13179; (b) providing advice to the Secretary, HHS, on the scientific validity and quality of dose reconstruction efforts performed for this program; and (c) upon request by the Secretary, HHS, advise the Secretary on whether there is a class of employees at any Department of Energy facility who were exposed to radiation but for whom it is not feasible to estimate their radiation dose, and on whether there is reasonable likelihood that such radiation doses may have endangered the health of members of this class. The Subcommittee for Dose Reconstruction Reviews was established to aid the Advisory Board in carrying out its duty to advise the Secretary, HHS, on dose reconstruction. Matters To Be Discussed: The agenda for the Subcommittee meeting includes: discussion of dose reconstruction cases under review; OCAS dose reconstruction quality management and assurance activities. The agenda is subject to change as priorities dictate. In the event an individual cannot attend, written comments may be submitted. Any written comments received will be provided at the meeting and should be submitted to the contact person below well in advance of the meeting. Contact Person for More Information: Theodore Katz, Executive Secretary, NIOSH, CDC, 1600 Clifton Road, Mailstop E–20, Atlanta GA 30333, Telephone: (513) 533–6800, Toll Free: 1 (800) CDC–INFO, e-mail ocas@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. PO 00000 Frm 00052 Fmt 4703 Sfmt 4703 Dated: October 13, 2009. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E9–25390 Filed 10–21–09; 8:45 am] BILLING CODE 4163–19–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Child Health and Human Development Special Emphasis Panel; Outcomes Research in Orthotics and Prostetics. Date: November 17, 2009. Time: 10 a.m. to 3 p.m. Agenda: To review and evaluate grant applications. Place: Marriott Bethesda North, 5701 Marinelli Road, Bethesda, MD 20852. Contact Person: Anne Krey, Scientific Review Officer, Division of Scientific Review, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, 301–435–6908. (Catalogue of Federal Domestic Assistance Program Nos. 93.864, Population Research; 93.865, Research for Mothers and Children; 93.929, Center for Medical Rehabilitation Research; 93.209, Contraception and Infertility Loan Repayment Program, National Institutes of Health, HHS) Dated: October 16, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–25470 Filed 10–21–09; 8:45 am] BILLING CODE 4140–01–P E:\FR\FM\22OCN1.SGM 22OCN1

Agencies

[Federal Register Volume 74, Number 203 (Thursday, October 22, 2009)]
[Notices]
[Pages 54585-54586]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-25404]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel, Cardiovascular Regeneration.
    Date: November 8-10, 2009.
    Time: 4 p.m. to 4 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892. (Virtual Meeting.)
    Contact Person: Joseph Thomas Peterson, PhD, Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 4118, MSC 7814, Bethesda, MD 
20892. 301-443-8130.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel, Small Business: Biological Chemistry and Biophysics.
    Time: November 9-10, 2009.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 
Wisconsin Avenue, Bethesda, MD 20814.
    Contact Person: Sergei Ruvinov, PhD, Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 4158, MSC 7806, Bethesda, MD 20892. 301-435-
1180. ruvinser@csr.nih.gov.

    Name of Committee: AIDS and Related Research Integrated Review 
Group, AIDS Immunology and Pathogenesis Study Section.
    Date: November 10, 2009.
    Time: 8 a.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Ritz Carlton Hotel, 1150 22nd Street, NW., Washington, DC 
20037.
    Contact Person: Shiv A. Prasad, PhD, Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 5220, MSC 7852, Bethesda, MD 20892. 301-443-
5779. prasads@csr.nih.gov.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel, Social Science and Population Studies.
    Date: November 11-12, 2009.
    Time: 4 p.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Westin St. Francis Hotel, 335 Powell Street, San 
Francisco, CA 94102.
    Contact Person: Valerie Durrant, PhD, Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 3148, MSC 7770, Bethesda, MD 20892. (301) 435-
3554. durrantv@csr.nih.gov.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel, Small Business: Biomaterials, Delivery Systems, and 
Nanotechnology.
    Date: November 13, 2009.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Doubletree Hotel Bethesda, 8120 Wisconsin Avenue, 
Bethesda, MD 20814.
    Contact Person: Alexander Gubin, PhD, Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 4196, MSC 7812, Bethesda, MD 20892. 301-435-
2902. gubina@csr.nih.gov.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel, RFA-OD-09-008 BRDG-SPAN and RFA-OD-09-009 Catalyst ARRA 
Review Panel 7.
    Date: November 17-18, 2009.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: William F. Bolger Center, 9600 Newbridge Drive, Potomac, 
MD 20854.
    Contact Person: Rossana Berti, PhD, Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 3191, MSC 7846, Bethesda, MD 20892. 301-402-
6411. bertiros@csr.nih.gov.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel, BRDG-SPAN and Catalyst ARRA Grants: Population Sciences and 
Epidemiology.
    Date: November 18, 2009.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hilton Washington/Rockville, 1750 Rockville Pike, 
Rockville, MD 20852.
    Contact Person: Suzanne Ryan, PhD, Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 3139, Bethesda, MD 20892. (301) 435-1712. 
ryansj@csr.nih.gov.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel, Fellowship: Technology Development.
    Date: November 19, 2009.
    Time: 12 p.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892. (Telephone Conference Call.)
    Contact Person: Alessandra M. Bini, PhD, Scientific Review 
Officer, Center for

[[Page 54586]]

Scientific Review, National Institutes of Health, 6701 Rockledge 
Drive, Room 5142, MSC 7840, Bethesda, MD 20892. 301-435-1024. 
binia@csr.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: October 14, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-25404 Filed 10-21-09; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.